Cargando…
Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products
The European Commission intends to protect vertebrate wildlife populations by regulating plant protection product (PPP) active substances that have endocrine‐disrupting properties with a hazard‐based approach. In this paper we consider how the Commission's hazard‐based regulation and accompanyi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850575/ https://www.ncbi.nlm.nih.gov/pubmed/30520244 http://dx.doi.org/10.1002/ieam.4113 |
_version_ | 1783469453829210112 |
---|---|
author | Crane, Mark Hallmark, Nina Lagadic, Laurent Ott, Katharina Pickford, Dan Preuss, Thomas Thompson, Helen Thorbek, Pernille Weltje, Lennart Wheeler, James R |
author_facet | Crane, Mark Hallmark, Nina Lagadic, Laurent Ott, Katharina Pickford, Dan Preuss, Thomas Thompson, Helen Thorbek, Pernille Weltje, Lennart Wheeler, James R |
author_sort | Crane, Mark |
collection | PubMed |
description | The European Commission intends to protect vertebrate wildlife populations by regulating plant protection product (PPP) active substances that have endocrine‐disrupting properties with a hazard‐based approach. In this paper we consider how the Commission's hazard‐based regulation and accompanying guidance can be operationalized to ensure that a technically robust process is used to distinguish between substances with adverse population‐level effects and those for which it can be demonstrated that adverse effects observed (typically in the laboratory) do not translate into adverse effects at the population level. Our approach is to use population models within the adverse outcome pathway framework to link the nonlinear relationship between adverse effects at the individual and population levels in the following way: (1) use specific protection goals for focal wildlife populations within an ecosystem services framework; (2) model the effects of changes in population‐related inputs on focal species populations with individual‐based population models to determine thresholds between negligible and nonnegligible (i.e., adverse) population‐level effects; (3) compare these thresholds with the relevant endpoints from laboratory toxicity tests to determine whether they are likely to be exceeded at hazard‐based limits or the maximum tolerated dose/concentration from the experimental studies. If the population threshold is not exceeded, then the substance should not be classified as an endocrine disruptor with population‐relevant adversity unless there are other lines of evidence within a weight‐of‐evidence approach to challenge this. We believe this approach is scientifically robust and still addresses the political and legal requirement for a hazard‐based assessment. Integr Environ Assess Manag 2019;15:278–291. © 2018 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC) |
format | Online Article Text |
id | pubmed-6850575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68505752019-11-18 Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products Crane, Mark Hallmark, Nina Lagadic, Laurent Ott, Katharina Pickford, Dan Preuss, Thomas Thompson, Helen Thorbek, Pernille Weltje, Lennart Wheeler, James R Integr Environ Assess Manag Environmental Policy & Regulation The European Commission intends to protect vertebrate wildlife populations by regulating plant protection product (PPP) active substances that have endocrine‐disrupting properties with a hazard‐based approach. In this paper we consider how the Commission's hazard‐based regulation and accompanying guidance can be operationalized to ensure that a technically robust process is used to distinguish between substances with adverse population‐level effects and those for which it can be demonstrated that adverse effects observed (typically in the laboratory) do not translate into adverse effects at the population level. Our approach is to use population models within the adverse outcome pathway framework to link the nonlinear relationship between adverse effects at the individual and population levels in the following way: (1) use specific protection goals for focal wildlife populations within an ecosystem services framework; (2) model the effects of changes in population‐related inputs on focal species populations with individual‐based population models to determine thresholds between negligible and nonnegligible (i.e., adverse) population‐level effects; (3) compare these thresholds with the relevant endpoints from laboratory toxicity tests to determine whether they are likely to be exceeded at hazard‐based limits or the maximum tolerated dose/concentration from the experimental studies. If the population threshold is not exceeded, then the substance should not be classified as an endocrine disruptor with population‐relevant adversity unless there are other lines of evidence within a weight‐of‐evidence approach to challenge this. We believe this approach is scientifically robust and still addresses the political and legal requirement for a hazard‐based assessment. Integr Environ Assess Manag 2019;15:278–291. © 2018 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC) John Wiley and Sons Inc. 2019-01-30 2019-03 /pmc/articles/PMC6850575/ /pubmed/30520244 http://dx.doi.org/10.1002/ieam.4113 Text en © 2018 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC) This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Environmental Policy & Regulation Crane, Mark Hallmark, Nina Lagadic, Laurent Ott, Katharina Pickford, Dan Preuss, Thomas Thompson, Helen Thorbek, Pernille Weltje, Lennart Wheeler, James R Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title | Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title_full | Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title_fullStr | Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title_full_unstemmed | Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title_short | Assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
title_sort | assessing the population relevance of endocrine‐disrupting effects for nontarget vertebrates exposed to plant protection products |
topic | Environmental Policy & Regulation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850575/ https://www.ncbi.nlm.nih.gov/pubmed/30520244 http://dx.doi.org/10.1002/ieam.4113 |
work_keys_str_mv | AT cranemark assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT hallmarknina assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT lagadiclaurent assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT ottkatharina assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT pickforddan assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT preussthomas assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT thompsonhelen assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT thorbekpernille assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT weltjelennart assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts AT wheelerjamesr assessingthepopulationrelevanceofendocrinedisruptingeffectsfornontargetvertebratesexposedtoplantprotectionproducts |